High-dose ziprasidone-induced acute dystonia

Paul J. Rosenfield, Ragy R. Girgis, Roberto Gil

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

There are few clinical data describing the relative risks of extrapyramidal symptoms (EPS) at higher doses of ziprasidone (i.e., greater than 160 mg/day) when compared to lower doses. We report on a patient who displayed no EPS with ziprasidone 160 mg/day for several months, but did display marked, acute dystonic reactions on ziprasidone 240 mg/day. The observations from the present case indicate that high-dose, ziprasidone-induced acute dystonia may occur even if no such side effects have been experienced at doses up to and including 160 mg/day.

Original languageEnglish
Pages (from-to)546-547
Number of pages2
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume31
Issue number2
DOIs
StatePublished - 30 Mar 2007
Externally publishedYes

Keywords

  • Acute dystonia
  • Extrapyramidal symptoms (EPS)
  • High-dose
  • Schizophrenia
  • Side effects
  • Ziprasidone

Fingerprint

Dive into the research topics of 'High-dose ziprasidone-induced acute dystonia'. Together they form a unique fingerprint.

Cite this